UIMC1_HUMAN - dbPTM
UIMC1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID UIMC1_HUMAN
UniProt AC Q96RL1
Protein Name BRCA1-A complex subunit RAP80
Gene Name UIMC1
Organism Homo sapiens (Human).
Sequence Length 719
Subcellular Localization Nucleus . Localizes at sites of DNA damage at double-strand breaks (DSBs).
Protein Description Ubiquitin-binding protein. [PubMed: 24627472 Specifically recognizes and binds 'Lys-63'-linked ubiquitin]
Protein Sequence MPRRKKKVKEVSESRNLEKKDVETTSSVSVKRKRRLEDAFIVISDSDGEEPKEENGLQKTKTKQSNRAKCLAKRKIAQMTEEEQFALALKMSEQEAREVNSQEEEEEELLRKAIAESLNSCRPSDASATRSRPLATGPSSQSHQEKTTDSGLTEGIWQLVPPSLFKGSHISQGNEAEEREEPWDHTEKTEEEPVSGSSGSWDQSSQPVFENVNVKSFDRCTGHSAEHTQCGKPQESTGRGSAFLKAVQGSGDTSRHCLPTLADAKGLQDTGGTVNYFWGIPFCPDGVDPNQYTKVILCQLEVYQKSLKMAQRQLLNKKGFGEPVLPRPPSLIQNECGQGEQASEKNECISEDMGDEDKEERQESRASDWHSKTKDFQESSIKSLKEKLLLEEEPTTSHGQSSQGIVEETSEEGNSVPASQSVAALTSKRSLVLMPESSAEEITVCPETQLSSSETFDLEREVSPGSRDILDGVRIIMADKEVGNKEDAEKEVAISTFSSSNQVSCPLCDQCFPPTKIERHAMYCNGLMEEDTVLTRRQKEAKTKSDSGTAAQTSLDIDKNEKCYLCKSLVPFREYQCHVDSCLQLAKADQGDGPEGSGRACSTVEGKWQQRLKNPKEKGHSEGRLLSFLEQSEHKTSDADIKSSETGAFRVPSPGMEEAGCSREMQSSFTRRDLNESPVKSFVSISEATDCLVDFKKQVTVQPGSRTRTKAGRGRRRKF
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
9SumoylationPRRKKKVKEVSESRN
CCCHHHHHHHHHHCC
62.37-
9SumoylationPRRKKKVKEVSESRN
CCCHHHHHHHHHHCC
62.37-
9UbiquitinationPRRKKKVKEVSESRN
CCCHHHHHHHHHHCC
62.3721906983
9 (in isoform 1)Ubiquitination-62.3721890473
9 (in isoform 2)Ubiquitination-62.3721890473
9 (in isoform 5)Ubiquitination-62.3721890473
12PhosphorylationKKKVKEVSESRNLEK
HHHHHHHHHHCCCCC
30.8325159151
19UbiquitinationSESRNLEKKDVETTS
HHHCCCCCCCCCCCC
58.39-
20SumoylationESRNLEKKDVETTSS
HHCCCCCCCCCCCCC
58.60-
20SumoylationESRNLEKKDVETTSS
HHCCCCCCCCCCCCC
58.6028112733
20UbiquitinationESRNLEKKDVETTSS
HHCCCCCCCCCCCCC
58.6021906983
20 (in isoform 1)Ubiquitination-58.6021890473
20 (in isoform 2)Ubiquitination-58.6021890473
20 (in isoform 5)Ubiquitination-58.6021890473
24PhosphorylationLEKKDVETTSSVSVK
CCCCCCCCCCCCCCC
31.6528450419
25PhosphorylationEKKDVETTSSVSVKR
CCCCCCCCCCCCCCC
12.9028450419
26PhosphorylationKKDVETTSSVSVKRK
CCCCCCCCCCCCCCC
35.8428450419
27PhosphorylationKDVETTSSVSVKRKR
CCCCCCCCCCCCCCC
19.1325159151
29PhosphorylationVETTSSVSVKRKRRL
CCCCCCCCCCCCCCC
24.7023401153
31SumoylationTTSSVSVKRKRRLED
CCCCCCCCCCCCCCC
44.70-
31SumoylationTTSSVSVKRKRRLED
CCCCCCCCCCCCCCC
44.7028112733
31UbiquitinationTTSSVSVKRKRRLED
CCCCCCCCCCCCCCC
44.7021890473
31 (in isoform 1)Ubiquitination-44.7021890473
31 (in isoform 2)Ubiquitination-44.7021890473
31 (in isoform 5)Ubiquitination-44.7021890473
44PhosphorylationEDAFIVISDSDGEEP
CCCEEEEECCCCCCC
21.8425159151
46PhosphorylationAFIVISDSDGEEPKE
CEEEEECCCCCCCCH
40.5023927012
59UbiquitinationKEENGLQKTKTKQSN
CHHCCCCCCCCCHHH
57.96-
75SumoylationAKCLAKRKIAQMTEE
HHHHHHHHHHHCCHH
41.51-
75SumoylationAKCLAKRKIAQMTEE
HHHHHHHHHHHCCHH
41.5128112733
75UbiquitinationAKCLAKRKIAQMTEE
HHHHHHHHHHHCCHH
41.5121906983
75 (in isoform 1)Ubiquitination-41.5121890473
75 (in isoform 2)Ubiquitination-41.5121890473
75 (in isoform 5)Ubiquitination-41.5121890473
90SumoylationEQFALALKMSEQEAR
HHHHHHHHHHHHHHH
34.47-
90SumoylationEQFALALKMSEQEAR
HHHHHHHHHHHHHHH
34.4728112733
90UbiquitinationEQFALALKMSEQEAR
HHHHHHHHHHHHHHH
34.47906983
90 (in isoform 1)Ubiquitination-34.4721890473
90 (in isoform 2)Ubiquitination-34.4721890473
90 (in isoform 5)Ubiquitination-34.4721890473
97MethylationKMSEQEAREVNSQEE
HHHHHHHHHHCCHHH
47.87115490305
101PhosphorylationQEAREVNSQEEEEEE
HHHHHHCCHHHHHHH
44.1129255136
110 (in isoform 4)Ubiquitination-6.2921906983
112UbiquitinationEEEELLRKAIAESLN
HHHHHHHHHHHHHHH
44.08-
115 (in isoform 4)Ubiquitination-12.7521906983
124PhosphorylationSLNSCRPSDASATRS
HHHHCCCCCCCCCCC
26.8528555341
127PhosphorylationSCRPSDASATRSRPL
HCCCCCCCCCCCCCC
34.8528555341
129PhosphorylationRPSDASATRSRPLAT
CCCCCCCCCCCCCCC
27.0426714015
131PhosphorylationSDASATRSRPLATGP
CCCCCCCCCCCCCCC
33.6228176443
136PhosphorylationTRSRPLATGPSSQSH
CCCCCCCCCCCCCCC
58.2629116813
137 (in isoform 3)Ubiquitination-17.9321890473
139PhosphorylationRPLATGPSSQSHQEK
CCCCCCCCCCCCCCC
42.2128176443
140PhosphorylationPLATGPSSQSHQEKT
CCCCCCCCCCCCCCC
38.5423401153
142PhosphorylationATGPSSQSHQEKTTD
CCCCCCCCCCCCCCC
29.1428176443
146UbiquitinationSSQSHQEKTTDSGLT
CCCCCCCCCCCCCCC
50.59-
147PhosphorylationSQSHQEKTTDSGLTE
CCCCCCCCCCCCCCC
34.77-
163PhosphorylationIWQLVPPSLFKGSHI
HHHCCCHHHHCCCCC
40.1324719451
166SumoylationLVPPSLFKGSHISQG
CCCHHHHCCCCCCCC
65.87-
166UbiquitinationLVPPSLFKGSHISQG
CCCHHHHCCCCCCCC
65.87-
167 (in isoform 3)Ubiquitination-19.6821890473
168PhosphorylationPPSLFKGSHISQGNE
CHHHHCCCCCCCCCC
20.4520363803
171PhosphorylationLFKGSHISQGNEAEE
HHCCCCCCCCCCHHH
26.9829255136
175 (in isoform 4)Ubiquitination-65.3721906983
188SumoylationEPWDHTEKTEEEPVS
CCCCCCCCCCCCCCC
63.4928112733
188UbiquitinationEPWDHTEKTEEEPVS
CCCCCCCCCCCCCCC
63.49-
189PhosphorylationPWDHTEKTEEEPVSG
CCCCCCCCCCCCCCC
42.2523186163
190 (in isoform 4)Ubiquitination-72.0121906983
195PhosphorylationKTEEEPVSGSSGSWD
CCCCCCCCCCCCCCC
43.6125159151
197PhosphorylationEEEPVSGSSGSWDQS
CCCCCCCCCCCCCCC
24.8225159151
198PhosphorylationEEPVSGSSGSWDQSS
CCCCCCCCCCCCCCC
40.1325159151
200PhosphorylationPVSGSSGSWDQSSQP
CCCCCCCCCCCCCCC
29.4525159151
204PhosphorylationSSGSWDQSSQPVFEN
CCCCCCCCCCCCEEC
28.5929116813
205PhosphorylationSGSWDQSSQPVFENV
CCCCCCCCCCCEECC
32.6325159151
215UbiquitinationVFENVNVKSFDRCTG
CEECCCCCCCCCCCC
39.9521906983
215 (in isoform 1)Ubiquitination-39.9521890473
215 (in isoform 2)Ubiquitination-39.9521890473
218 (in isoform 4)Ubiquitination-52.4121906983
221PhosphorylationVKSFDRCTGHSAEHT
CCCCCCCCCCCCCCC
38.5328348404
224PhosphorylationFDRCTGHSAEHTQCG
CCCCCCCCCCCCCCC
36.3827794612
228PhosphorylationTGHSAEHTQCGKPQE
CCCCCCCCCCCCCCC
19.6327794612
232UbiquitinationAEHTQCGKPQESTGR
CCCCCCCCCCCCCCC
51.67-
236PhosphorylationQCGKPQESTGRGSAF
CCCCCCCCCCCCHHH
30.8025627689
237PhosphorylationCGKPQESTGRGSAFL
CCCCCCCCCCCHHHH
30.1025627689
239MethylationKPQESTGRGSAFLKA
CCCCCCCCCHHHHHH
35.66115490297
241PhosphorylationQESTGRGSAFLKAVQ
CCCCCCCHHHHHHHC
17.9425159151
245SumoylationGRGSAFLKAVQGSGD
CCCHHHHHHHCCCCC
39.81-
245AcetylationGRGSAFLKAVQGSGD
CCCHHHHHHHCCCCC
39.8126051181
245MethylationGRGSAFLKAVQGSGD
CCCHHHHHHHCCCCC
39.8142366373
245SumoylationGRGSAFLKAVQGSGD
CCCHHHHHHHCCCCC
39.8128112733
245UbiquitinationGRGSAFLKAVQGSGD
CCCHHHHHHHCCCCC
39.8121890473
245 (in isoform 1)Ubiquitination-39.8121890473
250PhosphorylationFLKAVQGSGDTSRHC
HHHHHCCCCCCCCCH
19.1928450419
253PhosphorylationAVQGSGDTSRHCLPT
HHCCCCCCCCCHHCC
31.0528450419
254PhosphorylationVQGSGDTSRHCLPTL
HCCCCCCCCCHHCCH
25.4330576142
260PhosphorylationTSRHCLPTLADAKGL
CCCCHHCCHHHCCCC
22.9426074081
265UbiquitinationLPTLADAKGLQDTGG
HCCHHHCCCCCCCCC
61.78-
273 (in isoform 4)Ubiquitination-13.6121906983
296 (in isoform 3)Ubiquitination-3.2021890473
304 (in isoform 3)Ubiquitination-33.7521890473
305UbiquitinationCQLEVYQKSLKMAQR
EHHHHHHHHHHHHHH
39.82-
308SumoylationEVYQKSLKMAQRQLL
HHHHHHHHHHHHHHH
39.00-
308SumoylationEVYQKSLKMAQRQLL
HHHHHHHHHHHHHHH
39.00-
308UbiquitinationEVYQKSLKMAQRQLL
HHHHHHHHHHHHHHH
39.00-
309 (in isoform 3)Ubiquitination-4.6921890473
314 (in isoform 2)Ubiquitination-6.5721890473
318UbiquitinationQRQLLNKKGFGEPVL
HHHHHCCCCCCCCCC
59.40-
319 (in isoform 2)Ubiquitination-37.0821890473
330PhosphorylationPVLPRPPSLIQNECG
CCCCCCCHHHHCCCC
40.5629255136
343PhosphorylationCGQGEQASEKNECIS
CCCCCCCHHHCCHHC
49.1229255136
350PhosphorylationSEKNECISEDMGDED
HHHCCHHCCCCCCCC
38.9230108239
350 (in isoform 3)Ubiquitination-38.9221890473
358UbiquitinationEDMGDEDKEERQESR
CCCCCCCHHHHHHHH
60.47-
364PhosphorylationDKEERQESRASDWHS
CHHHHHHHHHHHHHH
25.4724719451
372UbiquitinationRASDWHSKTKDFQES
HHHHHHHHCCCHHHH
46.86-
374UbiquitinationSDWHSKTKDFQESSI
HHHHHHCCCHHHHHH
61.3521906983
374 (in isoform 1)Ubiquitination-61.3521890473
378 (in isoform 2)Ubiquitination-46.5821890473
379PhosphorylationKTKDFQESSIKSLKE
HCCCHHHHHHHHHHH
26.9527732954
380PhosphorylationTKDFQESSIKSLKEK
CCCHHHHHHHHHHHH
33.0320068231
382SumoylationDFQESSIKSLKEKLL
CHHHHHHHHHHHHHH
52.24-
382SumoylationDFQESSIKSLKEKLL
CHHHHHHHHHHHHHH
52.2428112733
382UbiquitinationDFQESSIKSLKEKLL
CHHHHHHHHHHHHHH
52.2421890473
382 (in isoform 1)Ubiquitination-52.2421890473
383PhosphorylationFQESSIKSLKEKLLL
HHHHHHHHHHHHHHC
42.9020068231
387SumoylationSIKSLKEKLLLEEEP
HHHHHHHHHHCCCCC
42.7328112733
387UbiquitinationSIKSLKEKLLLEEEP
HHHHHHHHHHCCCCC
42.7321906983
387 (in isoform 1)Ubiquitination-42.7321890473
393 (in isoform 2)Ubiquitination-38.2721890473
395PhosphorylationLLLEEEPTTSHGQSS
HHCCCCCCCCCCCCC
44.1830576142
396PhosphorylationLLEEEPTTSHGQSSQ
HCCCCCCCCCCCCCC
29.4617525332
397PhosphorylationLEEEPTTSHGQSSQG
CCCCCCCCCCCCCCC
28.2628450419
401PhosphorylationPTTSHGQSSQGIVEE
CCCCCCCCCCCCEEE
29.2630576142
402PhosphorylationTTSHGQSSQGIVEET
CCCCCCCCCCCEEEE
25.2517525332
402 (in isoform 3)Ubiquitination-25.2521890473
407 (in isoform 3)Ubiquitination-54.3521890473
409PhosphorylationSQGIVEETSEEGNSV
CCCCEEEECCCCCCC
28.1228450419
410PhosphorylationQGIVEETSEEGNSVP
CCCEEEECCCCCCCC
36.6128450419
415PhosphorylationETSEEGNSVPASQSV
EECCCCCCCCHHHHH
40.0917525332
419PhosphorylationEGNSVPASQSVAALT
CCCCCCHHHHHHHHH
19.5417525332
421PhosphorylationNSVPASQSVAALTSK
CCCCHHHHHHHHHCC
15.9523312004
421 (in isoform 2)Ubiquitination-15.9521890473
426PhosphorylationSQSVAALTSKRSLVL
HHHHHHHHCCCEEEE
27.7227251275
427PhosphorylationQSVAALTSKRSLVLM
HHHHHHHCCCEEEEC
27.2427251275
428AcetylationSVAALTSKRSLVLMP
HHHHHHCCCEEEECC
40.5526051181
428SumoylationSVAALTSKRSLVLMP
HHHHHHCCCEEEECC
40.5528112733
428UbiquitinationSVAALTSKRSLVLMP
HHHHHHCCCEEEECC
40.5521906983
428 (in isoform 1)Ubiquitination-40.5521890473
430PhosphorylationAALTSKRSLVLMPES
HHHHCCCEEEECCCC
26.9425627689
443PhosphorylationESSAEEITVCPETQL
CCCCCEEEECCCCCC
21.2328348404
448PhosphorylationEITVCPETQLSSSET
EEEECCCCCCCCCCC
21.6928348404
451PhosphorylationVCPETQLSSSETFDL
ECCCCCCCCCCCEEC
23.2328348404
452PhosphorylationCPETQLSSSETFDLE
CCCCCCCCCCCEECC
40.5628102081
453PhosphorylationPETQLSSSETFDLER
CCCCCCCCCCEECCC
36.9628102081
455PhosphorylationTQLSSSETFDLEREV
CCCCCCCCEECCCCC
25.1328102081
463PhosphorylationFDLEREVSPGSRDIL
EECCCCCCCCCCHHH
20.8425159151
466PhosphorylationEREVSPGSRDILDGV
CCCCCCCCCHHHHHE
30.1130266825
466 (in isoform 3)Ubiquitination-30.1121890473
476 (in isoform 2)Ubiquitination-0.9921890473
480SumoylationVRIIMADKEVGNKED
EEEEECCCCCCCHHH
44.77-
480SumoylationVRIIMADKEVGNKED
EEEEECCCCCCCHHH
44.77-
480UbiquitinationVRIIMADKEVGNKED
EEEEECCCCCCCHHH
44.7721906983
480 (in isoform 1)Ubiquitination-44.7721890473
481 (in isoform 3)Ubiquitination-57.0921890473
485SumoylationADKEVGNKEDAEKEV
CCCCCCCHHHHHHHH
51.55-
485SumoylationADKEVGNKEDAEKEV
CCCCCCCHHHHHHHH
51.55-
485UbiquitinationADKEVGNKEDAEKEV
CCCCCCCHHHHHHHH
51.5521906983
485 (in isoform 1)Ubiquitination-51.5521890473
498PhosphorylationEVAISTFSSSNQVSC
HHHHEECCCCCCEEC
32.71-
509 (in isoform 3)Ubiquitination-56.8421890473
544SumoylationRQKEAKTKSDSGTAA
HHHHCCCCCCCCCCC
52.11-
544SumoylationRQKEAKTKSDSGTAA
HHHHCCCCCCCCCCC
52.1128112733
544UbiquitinationRQKEAKTKSDSGTAA
HHHHCCCCCCCCCCC
52.1121906983
544 (in isoform 1)Ubiquitination-52.1121890473
545PhosphorylationQKEAKTKSDSGTAAQ
HHHCCCCCCCCCCCC
42.0930576142
547PhosphorylationEAKTKSDSGTAAQTS
HCCCCCCCCCCCCCE
45.1730576142
549PhosphorylationKTKSDSGTAAQTSLD
CCCCCCCCCCCCEEC
23.8328555341
553PhosphorylationDSGTAAQTSLDIDKN
CCCCCCCCEECCCCC
26.9123312004
554PhosphorylationSGTAAQTSLDIDKNE
CCCCCCCEECCCCCC
16.3825159151
559SumoylationQTSLDIDKNEKCYLC
CCEECCCCCCCEEEE
68.30-
559SumoylationQTSLDIDKNEKCYLC
CCEECCCCCCCEEEE
68.3028112733
559UbiquitinationQTSLDIDKNEKCYLC
CCEECCCCCCCEEEE
68.3021906983
559 (in isoform 1)Ubiquitination-68.3021890473
562SumoylationLDIDKNEKCYLCKSL
ECCCCCCCEEEECCC
37.26-
562SumoylationLDIDKNEKCYLCKSL
ECCCCCCCEEEECCC
37.2625218447
562UbiquitinationLDIDKNEKCYLCKSL
ECCCCCCCEEEECCC
37.26-
564 (in isoform 3)Ubiquitination-26.6321890473
567UbiquitinationNEKCYLCKSLVPFRE
CCCEEEECCCCCCCE
44.20-
575PhosphorylationSLVPFREYQCHVDSC
CCCCCCEEEEEHHHH
16.5125690035
581PhosphorylationEYQCHVDSCLQLAKA
EEEEEHHHHHHHHHH
18.6825690035
587SumoylationDSCLQLAKADQGDGP
HHHHHHHHHHCCCCC
62.17-
587SumoylationDSCLQLAKADQGDGP
HHHHHHHHHHCCCCC
62.1728112733
587UbiquitinationDSCLQLAKADQGDGP
HHHHHHHHHHCCCCC
62.1721906983
587 (in isoform 1)Ubiquitination-62.1721890473
597PhosphorylationQGDGPEGSGRACSTV
CCCCCCCCCCCCCCC
24.3630576142
602PhosphorylationEGSGRACSTVEGKWQ
CCCCCCCCCCCCHHH
34.2123312004
603PhosphorylationGSGRACSTVEGKWQQ
CCCCCCCCCCCHHHH
23.5930576142
607SumoylationACSTVEGKWQQRLKN
CCCCCCCHHHHHHCC
28.46-
607AcetylationACSTVEGKWQQRLKN
CCCCCCCHHHHHHCC
28.4626051181
607SumoylationACSTVEGKWQQRLKN
CCCCCCCHHHHHHCC
28.4628112733
607UbiquitinationACSTVEGKWQQRLKN
CCCCCCCHHHHHHCC
28.46-
618UbiquitinationRLKNPKEKGHSEGRL
HHCCHHHCCCCHHHH
68.96-
627PhosphorylationHSEGRLLSFLEQSEH
CCHHHHHHHHHHCCC
32.1725159151
632PhosphorylationLLSFLEQSEHKTSDA
HHHHHHHCCCCCCCC
32.0923312004
635SumoylationFLEQSEHKTSDADIK
HHHHCCCCCCCCCCC
45.75-
635SumoylationFLEQSEHKTSDADIK
HHHHCCCCCCCCCCC
45.7528112733
635UbiquitinationFLEQSEHKTSDADIK
HHHHCCCCCCCCCCC
45.75-
636PhosphorylationLEQSEHKTSDADIKS
HHHCCCCCCCCCCCC
33.4728509920
637PhosphorylationEQSEHKTSDADIKSS
HHCCCCCCCCCCCCC
35.2928509920
642SumoylationKTSDADIKSSETGAF
CCCCCCCCCCCCCCE
48.7728112733
642UbiquitinationKTSDADIKSSETGAF
CCCCCCCCCCCCCCE
48.772190698
642 (in isoform 1)Ubiquitination-48.7721890473
643PhosphorylationTSDADIKSSETGAFR
CCCCCCCCCCCCCEE
33.4723403867
644PhosphorylationSDADIKSSETGAFRV
CCCCCCCCCCCCEEC
33.8928464451
646PhosphorylationADIKSSETGAFRVPS
CCCCCCCCCCEECCC
35.4423403867
653PhosphorylationTGAFRVPSPGMEEAG
CCCEECCCCCCHHHC
31.0919664994
656SulfoxidationFRVPSPGMEEAGCSR
EECCCCCCHHHCCCH
4.8321406390
661CarbamidationPGMEEAGCSREMQSS
CCCHHHCCCHHHHHH
4.4617322306
662PhosphorylationGMEEAGCSREMQSSF
CCHHHCCCHHHHHHC
30.2923927012
667PhosphorylationGCSREMQSSFTRRDL
CCCHHHHHHCCCCCC
26.5526074081
668PhosphorylationCSREMQSSFTRRDLN
CCHHHHHHCCCCCCC
17.4723401153
670PhosphorylationREMQSSFTRRDLNES
HHHHHHCCCCCCCCC
27.0926074081
677PhosphorylationTRRDLNESPVKSFVS
CCCCCCCCCCCEEEE
33.6429255136
680AcetylationDLNESPVKSFVSISE
CCCCCCCCEEEEHHH
41.377681407
681PhosphorylationLNESPVKSFVSISEA
CCCCCCCEEEEHHHH
30.9923927012
684PhosphorylationSPVKSFVSISEATDC
CCCCEEEEHHHHHCC
20.5628464451
686PhosphorylationVKSFVSISEATDCLV
CCEEEEHHHHHCCEE
17.4224732914
689PhosphorylationFVSISEATDCLVDFK
EEEHHHHHCCEEEEC
24.1624732914
696AcetylationTDCLVDFKKQVTVQP
HCCEEEECCCEEECC
37.5224468251
696SumoylationTDCLVDFKKQVTVQP
HCCEEEECCCEEECC
37.5228112733
696UbiquitinationTDCLVDFKKQVTVQP
HCCEEEECCCEEECC
37.52-
697SumoylationDCLVDFKKQVTVQPG
CCEEEECCCEEECCC
50.4228112733
697UbiquitinationDCLVDFKKQVTVQPG
CCEEEECCCEEECCC
50.42-
700PhosphorylationVDFKKQVTVQPGSRT
EEECCCEEECCCCCC
15.78-
705PhosphorylationQVTVQPGSRTRTKAG
CEEECCCCCCCCCCC
36.8428985074

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
44SPhosphorylationKinaseCSNK2A1P68400
GPS
46SPhosphorylationKinaseCSNK2A1P68400
GPS
205SPhosphorylationKinaseATMQ13315
PSP
205SPhosphorylationKinaseATRQ13535
PSP
402SPhosphorylationKinaseATMQ13315
GPS
627SPhosphorylationKinaseCHEK1O14757
GPS
677SPhosphorylationKinaseCDK1P06493
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of UIMC1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of UIMC1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
UBC_HUMANUBCphysical
17525341
BRCA1_HUMANBRCA1physical
17525341
BABA2_HUMANBREphysical
17525341
BRCC3_HUMANBRCC3physical
17525341
ALBU_HUMANALBphysical
19615732
BARD1_HUMANBARD1physical
19615732
BRCA1_HUMANBRCA1physical
19615732
CAZA1_HUMANCAPZA1physical
19615732
CAPZB_HUMANCAPZBphysical
19615732
CCNA2_HUMANCCNA2physical
19615732
CDK1_HUMANCDK1physical
19615732
ODO2_HUMANDLSTphysical
19615732
FA7_HUMANF7physical
19615732
NRDC_HUMANNRD1physical
19615732
PUR4_HUMANPFASphysical
19615732
RFC4_HUMANRFC4physical
19615732
CSKP_HUMANCASKphysical
19615732
ULA1_HUMANNAE1physical
19615732
CPNE1_HUMANCPNE1physical
19615732
UBA3_HUMANUBA3physical
19615732
CSN2_HUMANCOPS2physical
19615732
BAG5_HUMANBAG5physical
19615732
BABA2_HUMANBREphysical
19615732
ERP44_HUMANERP44physical
19615732
ABRX2_HUMANFAM175Bphysical
19615732
BABA1_HUMANBABAM1physical
19615732
SSU72_HUMANSSU72physical
19615732
NOP53_HUMANGLTSCR2physical
19615732
LIN7C_HUMANLIN7Cphysical
19615732
WDR48_HUMANWDR48physical
19615732
P5CR3_HUMANPYCRLphysical
19615732
BRCC3_HUMANBRCC3physical
19615732
THNS1_HUMANTHNSL1physical
19615732
ABRX1_HUMANFAM175Aphysical
19615732
DPY30_HUMANDPY30physical
19615732
BRCC3_HUMANBRCC3physical
18077395
MDC1_HUMANMDC1physical
21857162
MDC1_HUMANMDC1physical
21622030
BRCA1_HUMANBRCA1physical
21622030
P53_HUMANTP53physical
19433585
MDM2_HUMANMDM2physical
19433585
ABRX1_HUMANFAM175Aphysical
19261749
BABA2_HUMANBREphysical
19261749
BABA1_HUMANBABAM1physical
19261749
BRCC3_HUMANBRCC3physical
19261749
BABA1_HUMANBABAM1physical
19261746
BRCC3_HUMANBRCC3physical
19261746
ABRX1_HUMANFAM175Aphysical
19261748
BABA2_HUMANBREphysical
19261748
BRCC3_HUMANBRCC3physical
19261748
BABA1_HUMANBABAM1physical
19261748
BRCA1_HUMANBRCA1physical
19261748
SUMO2_HUMANSUMO2physical
22689573
UBC_HUMANUBCphysical
22689573
BRCA1_HUMANBRCA1physical
17621610
ABRX1_HUMANFAM175Aphysical
17525340
BRCA1_HUMANBRCA1physical
17525340
CTIP_HUMANRBBP8physical
17525340
UBC_HUMANUBCphysical
22350954
ESR1_HUMANESR1physical
17311814
UBC_HUMANUBCphysical
19944020
ABRX1_HUMANFAM175Aphysical
17643121
ECM29_HUMANKIAA0368physical
20682791
UBC_HUMANUBCphysical
19536136
UBC_HUMANUBCphysical
19305427
ABRX1_HUMANFAM175Aphysical
19305427
BRCC3_HUMANBRCC3physical
19305427
BRCA1_HUMANBRCA1physical
19305427
ABRX1_HUMANFAM175Aphysical
19015238
BABA2_HUMANBREphysical
19015238
BRCC3_HUMANBRCC3physical
19015238
UBC_HUMANUBCphysical
19015238
H2A2C_HUMANHIST2H2ACphysical
19015238
H2B2E_HUMANHIST2H2BEphysical
19015238
CEP57_MOUSECep57physical
12954732
ABRX1_HUMANFAM175Aphysical
17643122
SUMO2_HUMANSUMO2physical
23211528
UBC_HUMANUBCphysical
23211528
BLM_HUMANBLMphysical
23708797
ELOA1_YEASTELA1physical
23993092
ELOC_YEASTELC1physical
23993092
UBC_HUMANUBCphysical
24627472
C1QBP_HUMANC1QBPphysical
23264621
HSP74_HUMANHSPA4physical
23264621
BRCC3_HUMANBRCC3physical
23264621
CDK1_HUMANCDK1physical
23264621
RS6_HUMANRPS6physical
23264621
ABRX1_HUMANFAM175Aphysical
23264621
FANCG_HUMANFANCGphysical
25132264
H2A2C_HUMANHIST2H2ACphysical
25132264
UBC_HUMANUBCphysical
22605335
UBC_HUMANUBCphysical
17311814
UBC_HUMANUBCphysical
23823328
UBC_HUMANUBCphysical
23562397
UBC_HUMANUBCphysical
25756347
PARP1_HUMANPARP1physical
25252691
BRCA1_HUMANBRCA1physical
25252691
ABRX1_HUMANFAM175Aphysical
25252691
SUMO2_HUMANSUMO2physical
26719330
TRAIP_HUMANTRAIPphysical
26781088
RIOX2_HUMANMINAphysical
28514442
C1QBP_HUMANC1QBPphysical
28842250
UBP13_HUMANUSP13physical
28569838
BRCA1_HUMANBRCA1physical
28569838
ABRX1_HUMANFAM175Aphysical
28569838
BABA1_HUMANBABAM1physical
28569838

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of UIMC1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44; SER-46; SER-627;SER-653 AND SER-677, AND MASS SPECTROMETRY.
"RAP80 responds to DNA damage induced by both ionizing radiation andUV irradiation and is phosphorylated at Ser 205.";
Yan J., Yang X.-P., Kim Y.-S., Jetten A.M.;
Cancer Res. 68:4269-4276(2008).
Cited for: PHOSPHORYLATION AT SER-205, AND MUTAGENESIS OF SER-205.
"Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damageresponse.";
Kim H., Chen J., Yu X.;
Science 316:1202-1205(2007).
Cited for: FUNCTION, IDENTIFICATION IN THE BRCA1-A COMPLEX, SUBCELLULAR LOCATION,UBIQUITIN-BINDING, PHOSPHORYLATION AT SER-101, AND MUTAGENESIS OFALA-88; SER-92; ALA-113 AND SER-117.
"RAP80 targets BRCA1 to specific ubiquitin structures at DNA damagesites.";
Sobhian B., Shao G., Lilli D.R., Culhane A.C., Moreau L.A., Xia B.,Livingston D.M., Greenberg R.A.;
Science 316:1198-1202(2007).
Cited for: FUNCTION, IDENTIFICATION IN THE BRCA1-A COMPLEX, SUBCELLULAR LOCATION,UBIQUITIN-BINDING, AND PHOSPHORYLATION AT SER-101.
"Abraxas and RAP80 form a BRCA1 protein complex required for the DNAdamage response.";
Wang B., Matsuoka S., Ballif B.A., Zhang D., Smogorzewska A., Giyi S.,Elledge S.J.;
Science 316:1194-1198(2007).
Cited for: FUNCTION, SUBCELLULAR LOCATION, PHOSPHORYLATION AT SER-140; SER-402AND SER-419, AND MUTAGENESIS OF ALA-88; SER-92; ALA-113 AND SER-117.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-140; SER-402; SER-415AND SER-419, AND MASS SPECTROMETRY.
"The ubiquitin-interacting motif containing protein RAP80 interactswith BRCA1 and functions in DNA damage repair response.";
Yan J., Kim Y.S., Yang X.-P., Li L.-P., Liao G., Xia F., Jetten A.M.;
Cancer Res. 67:6647-6656(2007).
Cited for: FUNCTION, SUBCELLULAR LOCATION, MUTAGENESIS OF ALA-88 AND ALA-113, ANDPHOSPHORYLATION AT SER-205 AND SER-402.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44 AND SER-46, AND MASSSPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-597; SER-653 ANDSER-677, AND MASS SPECTROMETRY.

TOP